Sweden’s Ortivus sells US subsidiaries

  • 25 February 2010

Swedish clinical IT firm Ortivus has sold its US subsidiaries to American company Tritech Software Systems for €8.5m

Ortivus says it has made the disposal to enable it to streamline its core operations into a clear focus on advanced mobile and clinical decision support for modern medical care. The US subsidiaries focused on administrative systems primarily for ambulance services and other emergency services.

The company will focus on the development and sale of products and services for mobile clinical decision support for medical care.

"This business deal moves Ortivus one important step forward towards fully operating and developing its core operations. Health sector interest in mobile solutions as a way of enhancing efficiency and improving health outcomes is growing rapidly,” said chair of the board Jon Risfelt.

He added: “Ortivus, with its unique combination of clinical expertise and sound experience from the development of mobile computing systems, is especially well equipped to meet these medical care needs".

Ortivus is based in Danderyd, Sweden, and was founded in 1985. Ortivus has 100 employees in Sweden, US, Canada and UK. In total more than 2,600 emergency services, 1,000 ambulances and 500 hospital beds are equipped with Ortivus solutions.

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

Taking the robot out of the human to make more time for patient care

Taking the robot out of the human to make more time for patient care

A robotic process automation (RPA) programme implemented in June 2024 by Calderdale and Huddersfield NHS Foundation Trust (CHFT) at its two hospitals in West Yorkshire…
Digital Health Coffee Time Briefing ☕

Digital Health Coffee Time Briefing ☕

Today's news roundup covers Dictate.IT's new AI clinical assistant and an ORCHA-approved gardening app to support mental wellbeing.
Kidney Beam secures seed funding for exercise and lifestyle app

Kidney Beam secures seed funding for exercise and lifestyle app

An evidence-based kidney care app has secured £610,000 in seed funding, including a sizeable contribution from charity Kidney Research UK.